- Previous Close
0.0340 - Open
0.0340 - Bid 0.0320 x --
- Ask 0.0340 x --
- Day's Range
0.0320 - 0.0340 - 52 Week Range
0.0210 - 0.1000 - Volume
551,114 - Avg. Volume
676,991 - Market Cap (intraday)
53.56M - Beta (5Y Monthly) -0.44
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings Date Feb 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia and the United States. The company develops, produces, and sells mobile health applications. Its products include wheezo, a wheeze rate detector; respiri mobile application; and Respiri health portal. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. The company was incorporated in 1987 and is based in Melbourne, Australia.
respiri.coRecent News: RSH.AX
View MorePerformance Overview: RSH.AX
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RSH.AX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RSH.AX
View MoreValuation Measures
Market Cap
53.56M
Enterprise Value
52.40M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
88.58
Price/Book (mrq)
11.12
Enterprise Value/Revenue
116.55
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-71.04%
Return on Equity (ttm)
-181.82%
Revenue (ttm)
1.85M
Net Income Avi to Common (ttm)
-7.58M
Diluted EPS (ttm)
-0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.25M
Total Debt/Equity (mrq)
1.81%
Levered Free Cash Flow (ttm)
-5.17M